Question 1

Has Irene Abramovich received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $351,706 in general payments to Irene Abramovich across 774 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Irene Abramovich did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Irene Abramovich come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	192	$104,818
Alkermes, Inc.	109	$53,258
Supernus Pharmaceuticals, Inc.	90	$51,544
Teva Pharmaceuticals USA, Inc.	50	$43,054
Axsome Therapeutics, Inc.	42	$34,545
E.r. Squibb & Sons, L.L.C.	35	$30,433
Neurocrine Biosciences, Inc.	34	$21,707
AbbVie(2 entities)	123	$8,677
Idorsia Pharmaceuticals US Inc	2	$2,030
Jazz Pharmaceuticals Inc.	1	$800
Lundbeck LLC	57	$581
Sunovion Pharmaceuticals Inc.	35	$166
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$47
Tris Pharma Inc	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	1	$15

Irene Abramovich

Payments from drug & device makers

Who reported the general payments

How this compares

Other psychiatry in West Hartford